Arsenal Medical key facts
as of Oct 2026- Developer of novel therapeutic in-situ forming materials designed to improve the clinical-stage drug delivery system.
- Arsenal Medical is valued at approximately $124.0M as of Oct 2026, set at its later-stage round, Jun 2025; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $46.8M across 4 recorded rounds; the latest was Early Stage VC ($6.0M) in May 2019.
- Notable investors include MedTech Innovator, Springboard Enterprises, National Institutes of Health, Polaris Partners, North Bridge Venture Partners — 7 tracked in total.
- Arsenal Medical has filed 18 Form Ds with the SEC since 2009, most recently Jun 2023 ($50.0M sold to 24 investors).
- Status: Privately Held (backing).
Valued at $124.0M at its later-stage round, Jun 2025. Nothing has traded since.
- ·Watch Arsenal Medical: the Monday email on marks, rounds and moves
Arsenal Medical funding rounds
4 roundsArsenal Medical valuation
Arsenal Medical was valued at $124 million at its later-stage round in Jun 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Arsenal Medical raised?
Arsenal Medical has raised $46.8 million in total; 4 of its rounds are on record, from 2012 on. The largest on record was a $6 million early-stage round in May 2019.
Arsenal Medical has filed 18 Form Ds with the SEC since 2009, most recently in Jun 2023 ($50 million sold to 24 investors).
Arsenal Medical investors
7 investors are on record for Arsenal Medical, including MedTech Innovator, Springboard Enterprises, National Institutes of Health and Polaris Partners. The early-stage round in May 2019 drew 12 investors.
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Imbria Pharmaceuticals ($132 million), Tahoe ($131 million) and Vivace Therapeutics ($125 million).
About Arsenal Medical
Developer of novel therapeutic in-situ forming materials designed to improve the clinical-stage drug delivery system. The company's products use safe, non-toxic, and biocompatible materials for therapy in intricate spaces without direct visualization, enabling healthcare professionals to provide local therapy for acute hemorrhage and other critical clinical conditions, including vascular injury and repair.
- Industry
- Drug Discovery
- Sector
- Healthcare
- HQ
- Waltham, MA, United States
- Founded
- 2005
- Employees
- 27
- Website
- arsenalmedical.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.